Boston Massachusetts based Inozyme Pharma is raising $67,399,993.00 in New Equity Investment.
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Inozyme Pharma is raising $67,399,993.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Axel Bolte played a…